Key result
A multicondition collaborative treatment program provided a mean of 114 additional depression-free days (95% CI, 79-149) and 0.335 additional QALYs over 24 months compared with usual care.
Why the study?
Does a multicondition collaborative treatment program improve quality-adjusted life-years and reduce costs in adults with depression and poorly controlled diabetes or CHD?
Population
214 adults with depressive disorder and poorly controlled diabetes mellitus, coronary heart disease, or both
Comparison
Multicondition collaborative treatment program… vs Usual primary care (UC)
Design
RCT, Randomized, Blinded assessments
Follow-up
24 months
Loading...
Supports collaborative care integration for depression with diabetes or CHD; extends RCT evidence for multicondition management improving outcomes.
RCT (n=214)
Blinded outcome assessment
Yes
Does a multicondition collaborative treatment program improve quality-adjusted life-years and reduce costs in adults with depression and poorly controlled diabetes or CHD?
Mean Difference: 114 (95% CI 79–149)
A multicondition collaborative care intervention for patients with depression and poorly controlled diabetes or CHD improves quality of life and depression-free days without increasing overall outpatient costs.
A 2012 study conducted an RCT in Depression and poorly controlled diabetes mellitus, coronary heart disease (CHD), or both (n=214). Multicondition collaborative treatment program (TEAMcare) vs. Usual primary care (UC) was evaluated on Additional depression-free days (MD 114, 95% CI 79 to 149). A multicondition collaborative treatment program provided a mean of 114 additional depression-free days (95% CI, 79-149) and 0.335 additional QALYs over 24 months compared with usual care.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: